<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-110341" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nevus of Ota and Ito</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Agarwal</surname>
            <given-names>Prateek</given-names>
          </name>
          <aff>Cleveland Clinic Abu Dhabi</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Bhupendra C.</given-names>
          </name>
          <aff>University of Utah</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prateek Agarwal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bhupendra Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-110341.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Ocular dermal melanosis, also known as nevus of Ota or oculodermal melanocyte, is benign melanosis that involves the distribution of the trigeminal nerve, mainly the ophthalmic and the maxillary divisions with associated hyperpigmentation of the eye and its adnexa. It occurs most commonly unilaterally. There is an increased risk of uveal melanoma and glaucoma in these cases. This activity reviews the evaluation and clinical diagnosis of nevus of Ota and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review histopathology of nevus of Ota.</p></list-item><list-item><p>Describe the appropriate evaluation steps for a possible nevus of Ota.</p></list-item><list-item><p>Outline treatment options for nevus of Ota.</p></list-item><list-item><p>Summarize the importance of improving care coordination amongst the interprofessional team to enhance the delivery of care for patients with nevus of Ota.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=110341&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=110341">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-110341.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Nevus of Ota is a benign melanosis that primarily involves the region of the trigeminal nerve distribution. The first and second divisions of the trigeminal nerve, namely the ophthalmic V1 and the maxillary V2 are most commonly involved. There is associated hyperpigmentation of the eye. Nevus of Ota is also known as ocular dermal melanosis.<xref ref-type="bibr" rid="article-110341.r1">[1]</xref><xref ref-type="bibr" rid="article-110341.r2">[2]</xref></p>
        <p>The characteristic gray-blue hyperpigmentation occurs due to entrapped melanocytes. Unilateral presentation is more common. The melanocytes are entrapped leading to gray-blue hyperpigmentation of the conjunctiva and sclera along with ipsilateral facial skin. There is an increased risk of uveal melanoma and glaucoma in these cases.<xref ref-type="bibr" rid="article-110341.r3">[3]</xref>&#x000a0;Palatal involvement may also occur.<xref ref-type="bibr" rid="article-110341.r4">[4]</xref>&#x000a0;</p>
        <p>Nevus of Ito is very similar to nevus of Ota except it differs in the territory of distribution. It was described by Minor Ota in 1954. It involves the distribution territory of lateral cutaneous brachial nerves of the shoulder and posterior supraclavicular nerves. Both of these diseases share similar pathophysiology.</p>
      </sec>
      <sec id="article-110341.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact etiology is unknown, and various hypotheses have been proposed:</p>
        <list list-type="bullet">
          <list-item>
            <p>Melanocytes do not migrate from neural crest cells to the basal layer of the epidermis</p>
          </list-item>
          <list-item>
            <p>History of previous radiotherapy/radiation exposure/hormonal factors</p>
          </list-item>
          <list-item>
            <p>The genes BRAF<italic toggle="yes">&#x000a0;</italic>and&#x000a0;NRAS&#x000a0;of the MAP kinase pathway have been implicated. G-coupled protein,&#x000a0;GNAQ is found to be mutated causing the G-coupled protein to be constitutively turned on</p>
          </list-item>
          <list-item>
            <p>During embryogenesis, the melanoblasts migrate to skin and uvea causing the typical bluish-gray pigmentation in these sites&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Monosomy of chromosome 3 and gain of the long arm of chromosome 8q is a significant risk factor for uveal melanoma and poor outcome.<xref ref-type="bibr" rid="article-110341.r5">[5]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-110341.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The Asian population is more commonly involved affecting 0.014% to 0.034% of the population. Most commonly, they present at birth, but lesions can also appear in puberty or during pregnancy due to hormonal changes. Females are more commonly affected than males at a ratio of 5:1.<xref ref-type="bibr" rid="article-110341.r6">[6]</xref>&#x000a0;It is more common in people of Asian and African descent and&#x000a0;less common in Whites.<xref ref-type="bibr" rid="article-110341.r7">[7]</xref>&#x000a0;Though the risk of malignant melanoma is much more in Whites than in other races.</p>
        <p>Nevus of Ito also presents during infancy or at the time of puberty. Asian populations and dark skin races are affected more commonly. Nevus of Ota is also sometimes found to be associated with nevus of Ito.<xref ref-type="bibr" rid="article-110341.r8">[8]</xref></p>
      </sec>
      <sec id="article-110341.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>There is hyperpigmentation of the eye and surrounding adnexa along the distribution of the first and second divisions of the trigeminal nerve, namely the ophthalmic V1 and the maxillary V2 divisions. The hyperpigmentation is visible as a bluish pigmentation of the eyes and periocular region. The dermis contains excessive melanocytes, which can transform into malignant melanoma.<xref ref-type="bibr" rid="article-110341.r9">[9]</xref></p>
      </sec>
      <sec id="article-110341.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Pathology shows numerous melanocytes in the dermis. These pigmented melanocytes are spindle-shaped or dendritic in shape. The Mongolian spot differs from the nevus of Ota in having melanocytes primarily concentrated in the deeper layer of the dermis, whereas in the nevus of&#x000a0;Ota, the melanocytes are more superficially concentrated. Nevus of Ota can be classified into 5 types based on the location of dermal melanocytes, namely:</p>
        <list list-type="bullet">
          <list-item>
            <p>Superficial</p>
          </list-item>
          <list-item>
            <p>Superficial dominant</p>
          </list-item>
          <list-item>
            <p>Diffuse</p>
          </list-item>
          <list-item>
            <p>Deep dominant</p>
          </list-item>
          <list-item>
            <p>Deep</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-110341.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Nevus of Ota is usually asymptomatic though rare cases with sensory loss have also been reported. It is characterized by bluish hyperpigmentation along the ophthalmic and maxillary divisions (V1 and V2) of the trigeminal nerve. The nevus of Ota is usually unilateral or sometimes bilateral. Morphology can be macular (rarely papular or nodular), patchy brown, slate-blue or with grey-black pigmentation, and deeper lesions appearing blue. Macules are confluent, non-hairy, and flat with poorly defined margins. Pigmentation may affect extracutaneous sites like the eyes (conjunctiva, sclera, cornea, and uvea). Pigmentation may&#x000a0;also affect the oral cavity and nasal mucosa.</p>
        <p>A complete ophthalmic examination, including visual acuity testing, intraocular pressure measurement, slit-lamp examination of the anterior segment, and dilated fundus examination with an indirect ophthalmoscope, should be performed. Subconjunctival melanosis and episcleral pigmentation are well appreciated on slit-lamp examination. Gonioscopy should be performed to note the hyperpigmentation of trabecular meshwork. A dilated peripheral retinal examination should be performed to rule out any choroidal mass/choroidal melanoma. Stereoscopic examination of the optic nerve head should be done to document any optic nerve head cupping. An oral examination is performed to look for palate lesions.</p>
        <p>Tanino&#x000a0;classifies nevus of Ota into 4 types:<xref ref-type="bibr" rid="article-110341.r10">[10]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Type I (mild): Type A is periocular. Type B involves&#x000a0;the zygomatic region. Type C involves the forehead. Type D&#x000a0;involves the only nose.</p>
          </list-item>
          <list-item>
            <p>Type II (moderate): Similar to type I but worse in severity.</p>
          </list-item>
          <list-item>
            <p>Type III (intensive): Periocular, nose, and scalp involvement.</p>
          </list-item>
          <list-item>
            <p>Type IV: Bilateral involvement.</p>
          </list-item>
        </list>
        <p>The only difference between the nevus of Ota and the nevus of Ito is the&#x000a0;site of involvement and distribution. Ocular complications are not seen in the nevus of Ito. The intensity of pigmentation in both of these nevi may vary with menstruation, fatigue, or weather. Pigmentation becomes more intense after puberty and remains permanent with no spontaneous regression.</p>
      </sec>
      <sec id="article-110341.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>There is no definitive diagnostic test to confirm the nevus of Ota and Ito. They are diagnosed mainly by clinical examination and history. Dermatoscopy shows bluish to slate grey homogeneous pigmentation. Skin biopsy is&#x000a0;mandated if the overlying skin develops ulceration, or there is a variation in pigmentation with the development of papules.</p>
        <p>Superficial variants tend to occur on the cheeks, while deeper variants affect periorbital areas, the temple, and the forehead. Periodic re-evaluation with an ophthalmologist should also be performed annually to rule out ocular complications.</p>
      </sec>
      <sec id="article-110341.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Ophthalmic</bold>
</p>
        <p>Ophthalmological screening and recording of vision, intraocular pressures, gonioscopy, comprehensive slit-lamp examination, and dilated fundus examination should be done to rule out any uveal melanomas. Management of uveal melanomas will depend on the size and location and will involve surgical resection, radiotherapy, transpupillary thermotherapy, or enucleation.<xref ref-type="bibr" rid="article-110341.r9">[9]</xref></p>
        <p>
<bold>Dermatologic</bold>
</p>
        <p>Treatment is required for cosmetic purposes or if there is any malignant transformation. Treatment depends on the size of the lesion and the extent of invasion. Mohs micrographic surgery can be employed to remove the lesions and reconstruct the periocular tissues. For more extensive lesions or metastasis, a combination of surgical excision along with radiotherapy, transpupillary thermotherapy, or chemotherapy may be tried.</p>
        <p>Lasers can be employed for the cosmetic treatment of skin lesions by destroying the melanocytes. Pulsed Q-switched laser surgery is the treatment of choice for nevi of Ota and Ito. It&#x000a0;targets dermal melanocytes and melanophages by their selective photothermal and photos mechanical destruction, thereby decreasing the pigmentation. Chemical peels, dermabrasion, electrocautery, or cryotherapy are&#x000a0;other modalities of treatment for cosmesis.<xref ref-type="bibr" rid="article-110341.r11">[11]</xref></p>
      </sec>
      <sec id="article-110341.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Diagnosis of nevus of Ota and Ito can be made based on its clinical morphology and sites of involvement.<xref ref-type="bibr" rid="article-110341.r12">[12]</xref>&#x000a0;Dermatosis that need to be considered in the differential diagnosis are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Mongolian spots &#x02013; mostly, the lesions are present in the lumbosacral area and rarely present over the face. They spontaneously resolve by the age of 3&#x000a0;to 6 years.</p>
          </list-item>
          <list-item>
            <p>Acquired bilateral nevus of Ota-like macules (ABNOM)- sclera and oral mucosa are not involved in ABNOM or Sun&#x02019;s nevus</p>
          </list-item>
          <list-item>
            <p>Melanoma metastasis</p>
          </list-item>
          <list-item>
            <p>Ecchymoses</p>
          </list-item>
          <list-item>
            <p>Vascular malformations</p>
          </list-item>
          <list-item>
            <p>Drug-induced hyperpigmentation is usually after the ingestion of drugs like minocycline, amiodarone, and gold</p>
          </list-item>
          <list-item>
            <p>Melasma - typically associated with pregnancy</p>
          </list-item>
          <list-item>
            <p>Oral melanotic macule - present over the palate, smaller in size with no involvement of sclera</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-110341.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Malignant degeneration is rare. The prognosis is good. Patients usually present for cosmetic reasons due to pigmentation of the sclera and iris. Rarely it may be associated with cavernous hemangioma of the optic disc.</p>
        <p>There is a 10.3% risk of glaucoma, and 1 in 400 patients developed malignant melanoma.&#x000a0;For these reasons, annual ophthalmological screening is mandated for the measurement of intraocular pressures and dilated indirect ophthalmoscopy.</p>
        <p>A skin biopsy should be done if clinical changes are suspected of malignant transformation. Ophthalmologic follow-up care is necessary for patients with increased intraocular pressure.</p>
        <p>Overall, these lesions are typically benign with an excellent prognosis with or without treatment. Yearly screening for ruling out glaucoma and malignant melanoma by an ophthalmologist and dermatologist is recommended.</p>
      </sec>
      <sec id="article-110341.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The main social impact of nevi of Ota and Ito is the cosmetic concern. In nevus of Ota, where the sclera is commonly affected, ocular complications like increased intraocular pressure and glaucoma can occur. Malignant melanoma has also been reported, which occurs mainly on the skin, but meninges and ocular areas can also be involved.</p>
      </sec>
      <sec id="article-110341.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be taught that nevus of Ota and Ito are benign lesions that may present as ipsilateral grayish-blue pigmentation along&#x000a0;the periocular region. The patient should be advised that transformation to malignancy is rare. The patients are counseled to seek immediate medical consultation if there is any change in the size and shape of the lesions. Instruct patients to schedule periodic follow-up visits with an ophthalmologist for the measurement of intraocular pressures.</p>
      </sec>
      <sec id="article-110341.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Nevus of Ota commonly presents initially to ophthalmologists or dermatologists as a cosmetic concern for the bluish discoloration of periocular skin and the sclera. It is primarily a clinical diagnosis, but there is an increased risk of glaucoma and uveal melanoma in these cases (10% and 1 in 400, respectively). It is important to have baseline measurements of the intraocular pressures, perform gonioscopy, and indirect ophthalmoscopy on the first visit. Serial monitoring of intraocular pressures is mandated to detect early glaucoma. Close interprofessional team coordination with ophthalmologists, dermatologists, and primary clinicians is indicated for the management of&#x000a0;these patients.</p>
      </sec>
      <sec id="article-110341.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=110341&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=110341">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/nevus-of-ota-and-ito/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=110341">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/110341/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=110341">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-110341.s16">
        <fig id="article-110341.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Nevus of Ota in a 3-year-old female: pigmentation of the eyelid skin and sclera Contributed by Professor Bhupendra C. K. Patel MD, FRCS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Nevus__of__Ota__composite" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-110341.s17">
        <fig id="article-110341.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Nevus of Ota in an adult: involvement of the V1 and V2 distribution of the trigeminal nerve and the sclera Contributed by Professor Bhupendra C. K. Patel MD, FRCS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Nevus__of__Ota-adult" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-110341.s18">
        <title>References</title>
        <ref id="article-110341.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>KOPF</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>WEIDMAN</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Nevus of Ota.</article-title>
            <source>Arch Dermatol</source>
            <year>1962</year>
            <month>Feb</month>
            <volume>85</volume>
            <fpage>195</fpage>
            <page-range>195-208</page-range>
            <pub-id pub-id-type="pmid">14458325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Egan</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Lucius</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Gerwels</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Mamalis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous malignant melanoma and oculodermal melanocytosis (nevus of Ota): report of a case and review of the literature.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1998</year>
            <month>May</month>
            <volume>38</volume>
            <issue>5 Pt 2</issue>
            <fpage>862</fpage>
            <page-range>862-5</page-range>
            <pub-id pub-id-type="pmid">9591805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hori</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takayama</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Circumscribed dermal melanoses. Classification and histologic features.</article-title>
            <source>Dermatol Clin</source>
            <year>1988</year>
            <month>Apr</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>315</fpage>
            <page-range>315-26</page-range>
            <pub-id pub-id-type="pmid">3378374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shetty</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Subhas</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Castellino</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Nevus of ota with buccal mucosal pigmentation: a rare case.</article-title>
            <source>Dent Res J (Isfahan)</source>
            <year>2011</year>
            <season>Winter</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-5</page-range>
            <pub-id pub-id-type="pmid">22132016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swann</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Kwong</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The naevus of Ota.</article-title>
            <source>Clin Exp Optom</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>93</volume>
            <issue>4</issue>
            <fpage>264</fpage>
            <page-range>264-7</page-range>
            <pub-id pub-id-type="pmid">20533926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Bley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>C&#x000e1;rdenas</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Nevus of Ota, a classic presentation.</article-title>
            <source>Med Clin (Barc)</source>
            <year>2019</year>
            <month>Jul</month>
            <day>19</day>
            <volume>153</volume>
            <issue>2</issue>
            <fpage>92</fpage>
            <pub-id pub-id-type="pmid">30591278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Redkar</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Rawat</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Warrier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jena</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Nevus of Ota.</article-title>
            <source>J Assoc Physicians India</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>70</fpage>
            <pub-id pub-id-type="pmid">27734644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Que</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Weston</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Suchecki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ricketts</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pigmentary disorders of the eyes and skin.</article-title>
            <source>Clin Dermatol</source>
            <year>2015</year>
            <season>Mar-Apr</season>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>147</fpage>
            <page-range>147-58</page-range>
            <pub-id pub-id-type="pmid">25704935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mashayekhi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zolotarev</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Sector (partial) oculo(dermal) melanocytosis in 89 eyes.</article-title>
            <source>Ophthalmology</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>118</volume>
            <issue>12</issue>
            <fpage>2474</fpage>
            <page-range>2474-9</page-range>
            <pub-id pub-id-type="pmid">22018683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>QN</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>HZ</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Zuo</surname>
                <given-names>YG</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jing</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>YL</given-names>
              </name>
            </person-group>
            <article-title>A new classification of nevus of Ota.</article-title>
            <source>Chin Med J (Engl)</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>126</volume>
            <issue>20</issue>
            <fpage>3910</fpage>
            <page-range>3910-4</page-range>
            <pub-id pub-id-type="pmid">24157155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alster</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Treatment of nevus of Ota by the Q-switched alexandrite laser.</article-title>
            <source>Dermatol Surg</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>7</issue>
            <fpage>592</fpage>
            <page-range>592-6</page-range>
            <pub-id pub-id-type="pmid">7606368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110341.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bisceglia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carosi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fania</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Ciommo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lomuto</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Nevus of Ota. Presentation of a case associated with a cellular blue nevus with suspected malignant degeneration and review of the literature].</article-title>
            <source>Pathologica</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>89</volume>
            <issue>2</issue>
            <fpage>168</fpage>
            <page-range>168-74</page-range>
            <pub-id pub-id-type="pmid">9411364</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
